|
ZNF624 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.823720E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.143400E-03 |
| Normal-vs-Stage2 |
1.880190E-01 |
| Normal-vs-Stage3 |
3.780700E-04 |
| Normal-vs-Stage4 |
1.58486999999319E-05 |
| Stage1-vs-Stage2 |
2.615000E-01 |
| Stage1-vs-Stage3 |
7.225600E-02 |
| Stage1-vs-Stage4 |
7.614700E-04 |
| Stage2-vs-Stage3 |
4.570000E-02 |
| Stage2-vs-Stage4 |
3.140200E-03 |
| Stage3-vs-Stage4 |
1.028170E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.775100E-04 |
| Normal-vs-AfricanAmerican |
6.274000E-02 |
| Normal-vs-Asian |
4.982400E-02 |
| Caucasian-vs-AfricanAmerican |
5.926200E-01 |
| Caucasian-vs-Asian |
1.789180E-01 |
| AfricanAmerican-vs-Asian |
7.168800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.570300E-02 |
| Normal-vs-Female |
8.182600E-04 |
| Male-vs-Female |
5.270400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.840600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.222700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.158200E-03 |
| Normal-vs-Age(81-100Yrs) |
5.069800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.902400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.840400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.416600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.363600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.895800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.116600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.021750E-04 |
| Classical-VS-Follicular |
8.221400E-01 |
| Classical-VS-Other |
4.519000E-01 |
| Classical-VS-Normal |
8.055300E-03 |
| Tall-VS-Follicular |
1.998350E-03 |
| Tall-VS-Other |
5.753200E-01 |
| Tall-VS-Normal |
3.53490000004619E-06 |
| Follicular-VS-Other |
4.954000E-01 |
| Follicular-VS-Normal |
1.007590E-02 |
| Other-VS-Normal |
1.105160E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.162100E-03 |
| Normal-vs-N1 |
9.70230000000294E-05 |
| N0-vs-N1 |
1.318330E-02 |
|
|
